Best of 2020: Top pharma stories
MM+M’s most popular pharma stories of the year spanned features the industry’s reaction to the death of George Floyd and COVID-19, surveys on how to navigate challenges due to the pandemic and more.
MM+M’s most popular pharma stories of the year spanned features the industry’s reaction to the death of George Floyd and COVID-19, surveys on how to navigate challenges due to the pandemic and more.
Justice Department takes aim at Walmart over opioid prescriptions; vaccine skepticism raises concerns; BMS suspends Opdivo trials in brain cancer.
The most-read media stories on MM+M included media acquisitions, Q&As with health media and point-of-care leaders and coverage of virtual health media events.
Texas deviates from CDC vaccination priority guidelines; Answering questions about the new strain of COVID-19; EU approves Pfizer/BioNTech vaccine.
Browse a list of MM+M’s most popular campaign stories from 2020 featuring videos, campaign mishaps, celebrities and more.
Family members ducked responsibility for Purdue’s marketing misdeeds, despite exerting substantial oversight over the company’s management for many years.
This week’s Haymarket Media Coronavirus Briefing is 1,358 words and will take you six minutes to read.
The company’s new president talks virtual agency life, leadership succession and plans/priorities.
Take a look back at the most-read agency stories of 2020 including agency reactions to the pandemic and George Floyd’s death, 2020 Agency 100 results and more.
Please login or register first to view this content.